Abstract:Abstract Background Synonymous mutations have been identified to play important roles in cancer development, although they do not modify the protein sequences. However, relatively little research has specifically delineated the functionality of synonymous mutations in cancer. Results We investigated the nucleotide-based and amino acid-based features of synonymous mutations across 15 cancer types from The Cancer Genome Atlas (TCGA), and revealed novel driver candidates by identifying hotspot mutations. Firstly, synonymous mutations were analyzed between TCGA and 1000 Genomes Project at nucleotide and amino acid levels. We found that C:G → T:A transitions were the most frequent single-base substitutions, and leucine underwent the largest number of synonymous mutations in TCGA due to prevalent C → T transition, which induced the transformation between optimal and non-optimal codons. Next, 97 synonymous hotspot mutations in 86 genes were nominated as candidate drivers with potential cancer risk by considering the mutational rates across different sequence contexts. We observed that non-CpG-island GC transition sequence context was positively selected across most of cancer types, and different sequence contexts under which hotspot mutations occur could be significance for genetic differences and functional features. We also found that the hotspots were more conserved than neutral mutations of hotspot-mutation-containing-genes and frequently happened at leucine. In addition, we mapped hotspots, neutral and non-hotspot mutations of hotspot-mutation-containing-genes to their respective protein domains and found ion transport domain was the most frequent one, which could mediate the cell interaction and had relevant implication for tumor therapy. And the signatures of synonymous hotspots were qualitatively similar with those of harmful missense variants. Conclusions We illustrated the preferences of cancer associated synonymous mutations, especially hotspots, and laid the groundwork for understanding the synonymous mutations act as drivers in cancer.

A Large-Scale Analysis of the Relationship of Synonymous SNPs Changing MicroRNA Regulation with Functionality and Disease

Bicodon bias can determine the role of synonymous SNPs in human diseases

Spontaneous Single Nucleotide Polymorphism in Porcine Microrna-378 Seed Region Leads to Functional Alteration.

Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

Investigating DNA-, RNA-, and Protein-Based Features As a Means to Discriminate Pathogenic Synonymous Variants.

An Analysis of Mutational Signatures of Synonymous Mutations Across 15 Cancer Types.

Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors

Genome-wide Identification of SNPs in Microrna Genes and the SNP Effects on Microrna Target Binding and Biogenesis

Epidemiological evidence for associations between variants in microRNA and cancer risk

An Analysis of Human Microrna and Disease Associations

Prediction of Functional Regulatory SNPs in Monogenic and Complex Disease.

Syntool: A Novel Region-Based Intolerance Score to Single Nucleotide Substitution for Synonymous Mutations Predictions Based on 123,136 Individuals.

Effects of Synonymous Mutations beyond Codon Bias: The Evidence for Adaptive Synonymous Substitutions from Microbial Evolution Experiments

Molecular Mechanisms and the Significance of Synonymous Mutations

SNP analysis reveals an evolutionary acceleration of the human-specific microRNAs

Genetic Study of Complex Diseases in the Post-GWAS Era

Regsnps-Splicing: a Tool for Prioritizing Synonymous Single-Nucleotide Substitution

Prime editor-based high-throughput screening reveals functional synonymous mutations in the human genome

Population-scale Genetic Control of Alternative Polyadenylation and Its Association with Human Diseases

Animal complexity defines the functionality of synonymous mutations through mediating microRNA regulations